Rare Pulmonology News
Advertisement
Disease Profile
Canavan disease
Prevalence estimates on Rare Medical Network websites are calculated based on data available from numerous sources, including US and European government statistics, the NIH, Orphanet, and published epidemiologic studies. Rare disease population data is recognized to be highly variable, and based on a wide variety of source data and methodologies, so the prevalence data on this site should be assumed to be estimated and cannot be considered to be absolutely correct.
Unknown
Age of onset
Infancy
ICD-10
E75.2
Inheritance
Autosomal dominant A pathogenic variant in only one gene copy in each cell is sufficient to cause an autosomal dominant disease.
Autosomal recessive Pathogenic variants in both copies of each gene of the chromosome are needed to cause an autosomal recessive disease and observe the mutant phenotype.
X-linked
dominant X-linked dominant inheritance, sometimes referred to as X-linked dominance, is a mode of genetic inheritance by which a dominant gene is carried on the X chromosome.
dominant X-linked dominant inheritance, sometimes referred to as X-linked dominance, is a mode of genetic inheritance by which a dominant gene is carried on the X chromosome.
X-linked
recessive Pathogenic variants in both copies of a gene on the X chromosome cause an X-linked recessive disorder.
recessive Pathogenic variants in both copies of a gene on the X chromosome cause an X-linked recessive disorder.
Mitochondrial or multigenic Mitochondrial genetic disorders can be caused by changes (mutations) in either the mitochondrial DNA or nuclear DNA that lead to dysfunction of the mitochondria and inadequate production of energy.
Multigenic or multifactor Inheritance involving many factors, of which at least one is genetic but none is of overwhelming importance, as in the causation of a disease by multiple genetic and environmental factors.
Not applicable
Other names (AKA)
Canavan-van Bogaert-Bertrand disease; Spongy degeneration of the central nervous system; Von Bogaert-Bertrand disease;
Categories
Congenital and Genetic Diseases
Summary
Canavan disease is a progressive, fatal, genetic disorder affecting the
Symptoms
- Damage to the optic nerve (Optic atrophy)
- Blindness
- Deafness (
Hearing loss ) - Increased head size (macrocephaly)
Intellectual disability anddevelopmental delay - Low muscle tone (
hypotonia ) - Gastroesophageal reflux
- Feeding difficulties in infancy
- Inability to straighten joints (Flexion
contractures ) - Difficulty holding up head when pulled into a seated position (Head lag)
- Abnormal growth of white matter in the brain (leukodystrophy)
- Sleep disturbances
Infants with Canavan disease appear normal at birth and usually develop symptoms between two and six months of age. These include low muscle tone, poor head control, an increased head size, and poor motor development. Later symptoms include optic nerve damage, blindness, and
This table lists symptoms that people with this disease may have. For most diseases, symptoms will vary from person to person. People with the same disease may not have all the symptoms listed. This information comes from a database called the Human Phenotype Ontology (HPO) . The HPO collects information on symptoms that have been described in medical resources. The HPO is updated regularly. Use the HPO ID to access more in-depth information about a symptom.
Medical Terms | Other Names |
Learn More:
HPO ID
|
---|---|---|
80%-99% of people have these symptoms | ||
Cognitive impairment |
Abnormality of cognition
Cognitive abnormality
Cognitive defects
Cognitive deficits
Intellectual impairment
Mental impairment
[ more ] |
0100543 |
0002353 | ||
Feeding difficulties in infancy | 0008872 | |
Global developmental delay | 0001263 | |
Optic atrophy | 0000648 | |
Reduced consciousness/confusion |
Disturbances of consciousness
Lowered consciousness
[ more ] |
0004372 |
30%-79% of people have these symptoms | ||
Abnormality of visual evoked potentials | 0000649 | |
Blindness | 0000618 | |
Gastroesophageal reflux |
Acid reflux
Acid reflux disease
Heartburn
[ more ] |
0002020 |
Hearing impairment |
Deafness
Hearing defect
[ more ] |
0000365 |
Hypertonia | 0001276 | |
Macrocephaly |
Increased size of skull
Large head
Large head circumference
[ more ] |
0000256 |
Muscular hypotonia |
Low or weak muscle tone
|
0001252 |
5%-29% of people have these symptoms | ||
Abnormality of retinal pigmentation | 0007703 | |
Loss of developmental milestones
Mental deterioration in childhood
[ more ] |
0002376 | |
Flexion contracture |
Flexed joint that cannot be straightened
|
0001371 |
Seizure | 0001250 | |
Percent of people who have these symptoms is not available through HPO | ||
Aplasia/Hypoplasia involving the |
Absent/underdeveloped central nervous system tissue
|
0002977 |
0000007 | ||
Brain atrophy |
Brain degeneration
Brain wasting
[ more ] |
0012444 |
CNS demyelination | 0007305 | |
Delayed closure of the anterior fontanelle |
Later than typical closing of soft spot of skull
|
0001476 |
Elevated urinary N-acetylaspartic acid level | 0032272 | |
Generalized-onset seizure | 0002197 | |
Increased circulating N-Acetylaspartic acid concentration | 0032273 | |
Increased CSF N-Acetylaspartic acid concentration | 0032274 | |
Involuntary, rapid, rhythmic eye movements
|
0000639 | |
Opisthotonus | 0002179 |
Diagnosis
Testing Resources
- The Genetic Testing Registry (GTR) provides information about the genetic tests for this condition. The intended audience for the GTR is health care providers and researchers. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional.
- Orphanet lists international laboratories offering diagnostic testing for this condition.
Treatment
Specialists who might be involved the care of someone with Canavan disease include:
Neurologist Ophthalmologist (eye doctor)- Genetics specialist (
genetic counselor and/orgeneticist ) Physical therapist Gastroenterologist
Organizations
Support and advocacy groups can help you connect with other patients and families, and they can provide valuable services. Many develop patient-centered information and are the driving force behind research for better treatments and possible cures. They can direct you to research, resources, and services. Many organizations also have experts who serve as medical advisors or provide lists of doctors/clinics. Visit the group’s website or contact them to learn about the services they offer. Inclusion on this list is not an endorsement by GARD.
Organizations Supporting this Disease
-
Canavan Foundation
450 West End Avenue, #6A
New York, NY 10024
Toll-free: 877-4-CANAVAN
Telephone: 212-873-4640
Fax: 212-873-7892
E-mail: [email protected]
Website: https://www.canavanfoundation.org -
Canavan Research Foundation
88 Route 37
New Fairfield, CT 06812
Telephone: 203-746-2436
Fax: 203-746-3205
E-mail: [email protected]
Website: https://www.canavan.org -
Canavan Research Illinois
PO Box 8194
Rolling Meadows, IL 60008-8194
Toll-free: 800-833-2194
E-mail: [email protected]
Website: https://www.canavanresearch.org -
Jewish Genetic Disease Consortium (JGDC)
450 West End Ave., 6A
New York, NY 10024
Toll-free: 866-370-GENE (4363)
Telephone: 855-642-6900
Fax: 212-873-7892
E-mail: [email protected]
Website: https://www.JewishGeneticDiseases.org
Learn more
These resources provide more information about this condition or associated symptoms. The in-depth resources contain medical and scientific language that may be hard to understand. You may want to review these resources with a medical professional.
Where to Start
- MedlinePlus was designed by the National Library of Medicine to help you research your health questions, and it provides more information about this topic.
- Genetics Home Reference (GHR) contains information on Canavan disease. This website is maintained by the National Library of Medicine.
- The National Institute of Neurological Disorders and Stroke (NINDS) collects and disseminates research information related to neurological disorders. Click on the link to view information on this topic.
- The National Organization for Rare Disorders (NORD) has a report for patients and families about this condition. NORD is a patient advocacy organization for individuals with rare diseases and the organizations that serve them.
In-Depth Information
- GeneReviews provides current, expert-authored, peer-reviewed, full-text articles describing the application of genetic testing to the diagnosis, management, and genetic counseling of patients with specific inherited conditions.
- The Monarch Initiative brings together data about this condition from humans and other species to help physicians and biomedical researchers. Monarch’s tools are designed to make it easier to compare the signs and symptoms (phenotypes) of different diseases and discover common features. This initiative is a collaboration between several academic institutions across the world and is funded by the National Institutes of Health. Visit the website to explore the biology of this condition.
- Online Mendelian Inheritance in Man (OMIM) is a catalog of human genes and genetic disorders. Each entry has a summary of related medical articles. It is meant for health care professionals and researchers. OMIM is maintained by Johns Hopkins University School of Medicine.
- Orphanet is a European reference portal for information on rare diseases and orphan drugs. Access to this database is free of charge.
- PubMed is a searchable database of medical literature and lists journal articles that discuss Canavan disease. Click on the link to view a sample search on this topic.
References
- Roscoe RB, Elliott C, Zarros A, Baillie GS. Non-genetic therapeutic approaches to Canavan disease.. J Neurol Sci. Jul 15, 2016; 366:116-124. https://www.ncbi.nlm.nih.gov/pubmed/27288788.
- Hoshino H, Kubota M. Canavan disease: clinical features and recent advances in research. Pediatr Int. Aug 2014; 56(4):477-83. https://www.ncbi.nlm.nih.gov/pubmed/24977939.
- Bokhari MR, Samanta D, Bokhari SRA. Canavan Disease. StatPearls. Updated Feb 21, 2020; www.ncbi.nlm.nih.gov/books/NBK430816.
- Matalon R, Delgado L, Michals-Matalon K. Canavan Disease. GeneReviews. Updated Sept 13, 2018; https://www.ncbi.nlm.nih.gov/books/NBK1234/.
- Kronn D, Oddoux C, Phillips J, Ostrer H. Prevalence of Canavan disease heterozygotes in the New York metropolitan Ashkenazi Jewish population.. Am J Hum Genet. 1995; 57(5):1250-1252. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1801394/.
- Feigenbaum A, Moore R, Clarke J, et al. Canavan disease: carrier-frequency determination in the Ashkenazi Jewish population and development of a novel molecular diagnostic assay.. AM J Med Genet A. 2004; 124A:142-147. https://www.ncbi.nlm.nih.gov/pubmed/14699612.
Rare Pulmonology News